11
Views
31
CrossRef citations to date
0
Altmetric
Review

Metabotropic glutamate receptors: novel targets for pain relief

Pages 207-224 | Published online: 10 Jan 2014

References

  • Basbaum AT. Distinct neurochemical features of acute and persistent pain. Proc. Natl Acad. Sc]. USA 96,7739–7743 (1999).
  • Coderre TJ, Katz J. Peripheral and central hyperexcitability: differential signs and symptoms in persistent pain. Behav. Brain Sci. 20,404–419 (1997).
  • Dickenson AH. Plasticity: implications for opioid and other pharmacological interventions in specific pain states. &hay. Brain Sc]. 20,392–403 (1997).
  • Dubner R, Gold M. The neurobiology of pain. Proc. Natl Acad. Sc]. USA 96,7627–7630 (1999).
  • Fields HL, Basbaum Pd. Central nervous system mechanisms of pain modulation. In: Textbook of Pain. Wall PD, Melzack R (Eds.), Churchill Livingstone, London, UK, 309–329 (1999).
  • Levine JD, Reichling DB. Peripheral mechanisms of inflammatory pain. In: Textbook of Pain. Wall PD, Melzack R (Eds.), Churchill Livingstone, London, UK, 59–84 (1999).
  • Moore IKA, Baba H, Woolf CJ. Synaptic transmission and plasticity in the superficial dorsal horn. Frog: Brain Res. 129,63–80 (2000).
  • Raja SN, Meyer RA, Ringkamp M, Campbell JN. Peripheral neural mechanisms of nociception. In: Textbook of Pain. Wall PD, Melzack R (Eds.), Churchill Livingstone, London, UK, 11–57 (1999).
  • Willis WD. Dorsal root potentials and dorsal root reflexes: a double-edged sword. Exp. Brain Res. 124,395–421 (1999).
  • Willis WD, Westlund KN. Neuroanatomy of the pain system and of the pathways that modulate pain. I Clin. Neumphysiol 14,2-31 (1997). itWood JN. Perl ER. Pain. Gun: Opin. Genetics Dev 9,328–332 (1999).
  • Woolf CJ, Salter MW. Neuronal plasticity: increasing the gain in pain. Science 288, 1765–1769 (2000).
  • Sandkahler J. Learning and memory in pain pathways. Pain 88,113–118 (2000).
  • Carlton SM. Peripheral excitatory amino acids. Cutr Opin. Pharmacol 1,52–56 (2001).
  • •• This review article provides the latest information about the role of peripheral excitatory amino acids and ionotropic glutamate receptors (iGluRs) in nociception.
  • Dickenson AH, Chapman V, Green GM. The pharmacology of excitatory and inhibitory amino acid-mediated events in the transmission and modulation of pain in the spinal cord. Gen. Pharmacol 28,633–638 (1997).
  • Fundytus ME. Glutamate receptors and nociception: implications for the drug treatment of pain. CNS Drugs 15,29–58 (2001).
  • Neugebauer V, Lucke T, Schaible HG. N- methyl-D-aspartate (NMDA) and non-NMDA receptor antagonists block the hyperexcitability of dorsal horn neurons during development of acute arthritis in rat's knee joint. I Neurophysiol 70, 1365–1377 (1993).
  • Randic M. Plasticity of excitatory synaptic transmission in the spinal cord dorsal horn. Progr. Brain Res. 113,463–506 (1996).
  • Sluka IKA, Willis WD. Increased spinal release of excitatory amino acids following intradermal injection of capsaicin is reduced by a protein kinase G inhibitor. Brain Res. 798,281–286 (1998).
  • Yaksh TL. Central pharmacology of nociceptive transmission. In: Textbook of Pain. Wall PD, Melzack R (Eds.), Churchill Livingstone, London, UK, 253–308 (1999).
  • Headley PM, Grillner S. Excitatory amino acids and synaptic transmission - the evidence for a physiological function. Tends Phatmacol Sci. 11,205–211 (1990).
  • Hollmann M, Heinemann S. Cloned glutamate receptors. Ann. Rev Neurosci. 17, 31–108 (1994).
  • Anwyl R. Metabotropic glutamate receptors: electrophysiological properties and role in plasticity. BtMn Res. Rev 29, 83–120 (1999).
  • Cartmell J, Schoepp DD. Regulation of neurotransmitter release by metabotropic glutamate receptors. I Neurochem. 75, 889–907 (2000).
  • Conn PJ, Pin J-P Pharmacology and functions of metabotropic glutamate receptors. Ann. Rev. Pharmacol Toxic& 37, 205–237 (1997).
  • Dingledine R, Borges K, Bowie D, Traynelis SE The glutamate receptor ion channels. Pharmacol Rev 51,7–61 (1999).
  • Pellicciari R, Costantino G. Metabotropic G-protein coupled glutamate receptors as therapeutic targets. Cutr Opin. Chem. Biol. 3, 433–440 (1999).
  • Schoepp DD, Jane DE, Monn JA. Pharmacological agents acting at subtypes of metabotropic glutamate receptors. Neuropharmacology 38,1431-1476 (1999). Molecular determinants of metabotropic glutamate receptor signaling. Wench Pharmacol. Sc]. 22, 114–120 (2001).
  • Karim F, Wang CC, Gereau RW.
  • ••First demonstration that spinal mGluR1and mGluR5 critically contribute to prolonged nociception through their coupling to the activation of ERK/ MAPKs.
  • Peavy RD, Conn PJ. Phosphorylation of mitogen-activated protein kinase in cultured rat cortical glia by stimulation of metabotropic glutamate receptors. Neurochem. 71, 603–612 (1998).
  • Albani-Torregrossa S, Attucci S, Marinozzi M, Pellicciari R, Moroni F, Pellegrini-Giampietro DE. Antagonist pharmacology of metabotropic glutamate receptors coupled to phospholipase D activation in adult rat hippocampus: focus on (2R, r S,2'R,3'S) -2 - (2' -carboxy-3' - phenylcyclopropyOglycine versus 3, 5-dihydroxyphenylglycine. Mol. Phalmacol. 55, 699–707 (1999).
  • Klein J, Reymann KG, Riedel G. Activation of phospholipases C and D by the novel metabotropic glutamate receptor agonist tADA. Neumpharmacology36, 261–263 (1997).
  • Pastorino L, Colciaghi F, Gardoni F et al. (+)-MCPG induces PKCepsilon translocation in cortical synaptosomes through a PLD-coupled mGluR. Eur. Neurosci 12, 1310–1318 (2000).
  • Shinomura T, del Rio E, Breen KC, Downes CP, McLaughlin M. Activation of phospholipase D by metabotropic glutamate receptor agonists in rat cerebrocortical synaptosomes. BE J. Pharmacol. 131, 1011–1018 (2000).
  • Heuss C, Scanziani M, Gaehwiler BH, Gerber U. G-protein-independent signaling mediated by metabotropic glutamate receptors. Nat. Neurosci 2, 1070–1077 (1999).
  • Neugebauer V, Keele NB, Shinnick- Gallagher P Loss of long-lasting potentiation mediated by group III mGluRs in amygdala neurons in kindling-induced epileptogenesis. I Neurophysiol. 78, 3475–3478 (1997).
  • Rush AM, Wu J, Rowan MJ, Anwyl R Activation of group II metabotropic glutamate receptors results in long-term potentiation following preconditioning stimulation in the dentate gyrus. Neuroscience 105, 335–341 (2001).
  • Ji RR, Baba H, Brenner GJ, Woolf CJ. Nociceptive-specific activation of ERIK in spinal neurons contributes to pain hypersensitivity. Nat. Neurosci 2, 1114–1119 (1999).
  • Malmberg AB. Protein kinase subtypes involved in injury-induced nociception. Progr Brain Res. 129, 51–59 (2000).
  • Sluka KA, Rees H, Chen PS, Tsuruoka M, Willis WD. Inhibitors of G-proteins and protein kinases reduce the sensitization to mechanical stimulation and the desensitization to heat of spinothalamic tract neurons induced by intradermal injection of capsaicin in the primate. Exp. Brain Res. 115, 15–24 (1997).
  • Sluka IKA, Willis WD. The effects of G- protein and protein kinase inhibitors on the behavioral responses of rats to intradermal injection of capsaicin. Pain 71, 165–178 (1997).
  • Stefani A, Pisani A, Mercuri NB, Calabresi P. The modulation of calcium currents by the activation of mGluRs. Mol. Neurobiol. 13, 81–95 (1996).
  • Matthews EA, Dickenson AH. Effects of spinally delivered N- and P-type voltage-dependent calcium channel antagonists on dorsal horn neuronal responses in a rat model of neuropathy. Pain 92, 235–246 (2001).
  • Neugebauer V, Vanegas H, Nebe J, Ramenapp P, Schaible HG. Effects of N-and L-type calcium channel antagonists on the responses of nociceptive spinal cord neurons to mechanical stimulation of the normal and the inflamed knee joint. Neurophysid 76, 3740–3749 (1996).
  • Schaible HG, Nebe J, Neugebauer V, Ebersberger A, Vanegas H. The role of high-threshold calcium channels in the spinal neuronal hyperexcitability induced by knee inflammation. Frog: Brain Res. 129, 173–190 (2000).
  • Chaplan SR, Pogrel JW, Yaksh TL. Role of voltage-dependent calcium channel subtypes in experimental tactile allodynia. Phatmacol. Exp. Ther. 269, 1117–1123 (1995).
  • Malmberg AB, Yaksh TL. Voltage-sensitive calcium channels in spinal nociceptive processing: blockade of N- and P-type channels inhibit formalin-induced nociception. j Neurosci. 14, 4882–4890 (1994).
  • Sluka IKA. Blockade of calcium channels can prevent the onset of secondary hyperalgesia and allodynia induced by intradermal injection of capsaicin in rats. Pain 71, 157–164 (1997).
  • Lujan R, Roberts JD, Shigemoto R, Ohishi H, Somogyi P. Differential plasma membrane distribution of metabotropic glutamate receptors mGluR1 alpha, mGluR2 and mGluR5, relative to neurotransmitter release sites. J. Chem. Neumanat. 13, 219–241 (1997).
  • Ottersen OP, Landsend AS. Organization of glutamate receptors at the synapse. Eur Neurosci 9, 2219–2224 (1997).
  • Carlton SM, Hargett GL, Coggeshall RE. Localization of metabotropic glutamate receptors 2/3 on primary afferent axons in the rat. Neuroscience 105, 957–969 (2001).
  • Petralia RS, Wang YX, Niedzielski AS, Wenthold RJ. The metabotropic glutamate receptors, mGluR2 and mGluR3, show unique postsynaptic, presynaptic and glial localizations. Neuroscience 71, 949–976 (1996).
  • Neugebauer V, Chen PS, Willis WD. Groups II and III metabotropic glutamate receptors differentially modulate brief and prolonged nociception in primate SI'l cells. J. Nurcphysiol. 84, 2998–3009 (2000).
  • ••This electrophysiological study demonstrates that a selective grouplImOuR agonist has no effect on normal transmission, but inhibits pain-related central sensitization of spinothalamic tract neurons.
  • Canepari M, Papageorgiou G, Corrie J, Watkins C, Ogden D. The conductance underlying the parallel fibre slow EPSP in rat cerebellar Purkinje neurones studied with photolytic release of L-glutamate. Physiol. 533, 765–772 (2001).
  • Dutar P, Petrozzino JJ, Vu HM, Schmidt Perkel DJ. Slow synaptic inhibition mediated by metabotropic glutamate receptor activation of GIRK channels. J. Neumphysiol. 84, 2284–2290 (2000).
  • Fiorillo CD, Williams JT. Glutamate mediates an inhibitory postsynaptic potential in dopamine neurons. Nature 394, 78–82 (1998).
  • Shen KZ, Johnson SW A slow excitatory postsynaptic current mediated by G-protein coupled metabotropic glutamate receptors in rat ventral tegmental dopamine neurons. Eur.j Neurosci 9, 48–54 (1997).
  • Bruno V, Battaglia G, Copani A et al. An activity-dependent switch from facilitation to inhibition in the control of excitotoxicity by group I metabotropic glutamate receptors. Eur Neumsci 13, 1469–1478 (2001).
  • Awad H, Hubert GW, Smith Y, Levey Al, Conn PJ. Activation of metabotropic glutamate receptor 5 has direct excitatory effects and potentiates NMDA receptor currents in neurons of the subthalamic nucleus. J. Neurosci 20, 7871–7879 (2000).
  • Bond A, Lodge D. Pharmacology of metabotropic glutamate receptor-mediated enhancement of responses to excitatory and inhibitory amino acids on rat spinal neurons in vivo. Neumpharmacology34, 1015–1023 (1995).
  • Budai D, Larson AA. The involvement of metabotropic glutamate receptors in sensory transmission in dorsal horn of the rat spinal cord. Neuroscience 83, 571–580 (1998).
  • Gerber G, Youn DH, Hsu CH, Isaev D, Randic M. Spinal dorsal horn synaptic plasticity: involvement of group I metabotropic glutamate receptors. Progr Brain Res 129, 115–134 (2000).
  • Chen J, Heinke B, Sandkahler J. Activation of group I metabotropic glutamate receptors induces long-term depression at sensory synapses in superficial spinal dorsal horn. Neuropharmacology39, 2231–2243 (2000).
  • Neugebauer V, Lucke T, Schaible HG. Requirement of metabotropic glutamate receptors for the generation of inflammation-evoked hyperexcitability in rat spinal cord neurons. Eur. j Neurosci 6, 1179–1186 (1994).
  • Alagarsami S, Sorensen SD, Conn PJ. Co- ordinate regulation of metabotropic glutamate receptors. CUI7: Opin. Neurobiol 11, 357–362 (2001).
  • Ali DW, Salter MW. NMDA receptor regulation by Sic kinase signalling in excitatory synaptic transmission and plasticity. Cum Opin. Neurobiol 11, 336–342 (2001).
  • Impey S, Obrietan K, Storm DR. Making new connections: role of ERIQMAPK signaling in neuronal plasticity. Neuron 23, 11–14 (1999).
  • Vinade L, Dosemeci A. Regulation of the phosphorylation state of the AMPA receptor G1uR1 subunit in the postsynaptic density. Cell Mol Neurobiol 20, 451–463 (2000).
  • Martin G, Nie Z, Siggins GR. Metabotropic glutamate receptors regulate N-methyl-D-aspartate-mediated synaptic transmission in nucleus accumbens. j Neurophysiol 78, 3028–3038 (1997).
  • Macek TA, Schaffhauser H, Conn PJ. Activation of PKC disrupts presynaptic inhibition by group II and group III metabotropic glutamate receptors and uncouples the receptor from GTP-binding proteins. Ann. NY Acad. Sc]. 868, 554–557 (1999).
  • Alagarsami S, Marino MJ, Rouse ST, Gereau RVV, Heinemann SF, Conn PJ. Activation of NMDA receptors reverses desensitization of mGluR5 in native and recombinant systems. Nat. Neurosci 2, 234–240 (1999).
  • Cuesta MC, Arcaya JL, Cano G, Sanchez L, Mabmer W, Suarez-Roca H. Opposite modulation of capsaicin-evoked substance P release by glutamate receptors. Neurochem. Int. 35, 471–478 (1999).
  • Maione S, Palazzo E, de Novellis V, Stella 1, Leyva J, Rossi E Metabotropic glutamate receptors modulate serotonin release in the rat periaqueductal gray matter. Naunyn-Schmiedeberis Arch. Pharmacol 358, 411–417 (1998).
  • Bordi F, Ugolini AR. Group I metabotropic glutamate receptors: implications for brain diseases. ffog: Neumbiol 59, 55–79 (1999).
  • Kingston AE, O'Neill MJ, Bond A eta]. Neuroprotective actions of novel and potent ligands of group I and group II metabotropic glutamate receptors. Ann. NY Acad. Sri. 890, 438–449 (1999).
  • Spooren WP, Gasparini F, Salt TE, Kuhn R. Novel allosteric antagonists shed light on mGlu (5) receptors and CNS disorders. Bends Pharmacol Sc]. 22, 331–337 (2001).
  • Spooren WP, Vassout A, Neijt HC et al. Anxiolytic-like effects of the prototypical metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyflpyridine in rodents. Pharmacol Exp. 7-her 295, 1267–1275 (2000).
  • Nicoletti F, Bruno V, Copani A, Casabona G, Knöpfel T Metabotropic glutamate receptors: a new target for the therapy of neurodegenerative disorders? Trends Neurosci 19, 267–271 (1996).
  • Coggeshall RE, Carlton SM. Receptor localization in the mammalian dorsal horn and primary afferent neurons. Brain Res. Rev 24, 28–66 (1997).
  • Du J, Koltzenburg M, Carlton SM. Glutamate-induced excitation and sensitization of nociceptors in rat glabrous skin. Pain 89, 187–198 (2001).
  • Lawand NB, Willis WD, Westlund KN. Excitatory amino acid receptor involvement in peripheral nociceptive transmission in rats. Eur Pharmacol 324, 169–177 (1997).
  • McNearney T, Speegle D, Lawand NB, Lisse J, Westlund KN. Excitatory amino acid profiles of synovial fluid from patients with arthritis. .1. Rheumatol. 27, 739–745 (2000).
  • Caldwell MD, Mastrofrancesco B, Shearer J, Bereiter D. The temporal change in amino acid concentration within wound fluid - a putative rationale. Progr Gun. Res. 365,205–222 (1991).
  • Lawand NB, McNearney T, Westlund KN. Amino acid release into the knee joint: key role in nociception and inflammation. Pain. 86, 69–74 (2000).
  • Nordlind K, Johansson O, Liden S, Hökfelt T Glutamate- and aspartate-like immunoreactivities in human normal and inflamed skin. Cell Path. Mol Path. 64, 75–82 (1993).
  • Sapolsky RM. Cellular defenses against excitotoxic insults. J. Neurochem. 76, 1601–1611 (2001).
  • Trang LE, Furst P, Odeback AC, Lovgren O. Plasma amino acids in rheumatoid arthritis. Scant/. Rheumatol 14, 393–402 (1985).
  • Neugebauer V Trends Neurosci 24, 550–552 (2001).
  • Bhave G, Karim F, Carlton SM, Gereau RVV. Peripheral group I metabotropic glutamate receptors modulate nociception in mice. Nat. Neurosci. 4, 417–423 (2001).
  • Walker K, Reeve A, Bowes M eta]. mG1u5 receptors and nociceptive function II. mG1u5 receptors functionally expressed on peripheral sensory neurones mediate inflammatory hyperalgesia. Neurophalmacology 40, 10–19 (2001).
  • Henry JL, Yashpal K, Pitcher GM, Coderre TJ. Physiological evidence that the `interphase' in the formalin test is due to active inhibition. Pain 82, 57–63 (1999).
  • Puig S, Sorkin LS. Formalin-evoked activity in identified primary afferent fibers: systemic lidocaine suppresses phase-2 activity. Pain 64, 345–355 (1996).
  • Kim SH, Chung JM. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 50, 355–363 (1992).
  • Dogrul A, Ossipov MET, Lai J, Malan TP, Porreca E Peripheral and spinal antihyperalgesic activity of SIB-1757, a metabotropic glutamate receptor (mGluR5) antagonist, in experimental neuropathic pain in rats. Neumsci. Lett. 292, 115–118 (2000).
  • Palecek J, Paleckova V, Dougherty PM, Willis WD. The effect of trans-ACPD, a metabotropic excitatory amino acid receptor agonist, on the responses of primate spinothalamic tract neurons. Pain 56, 261–269 (1994).
  • Young MR, Fleetwood-Walker SM, Mitchell R, Munro FE. Evidence for a role of metabotropic glutamate receptors in sustained nociceptive inputs to rat dorsal horn neurons. Neumpharmacology33, 141–144 (1994).
  • Alvarez FJ, Villalba RM, Carr PA, Grandes P, Somohano PM. Differential distribution of metabotropic glutamate receptors la, lb and 5 in the rat spinal cord. J. Comp. Neural 422, 464–487 (2000).
  • Berthele A, Boxall AJ, Urban A eta] Distribution and developmental changes in metabotropic glutamate receptor messenger RNA expression in the rat lumbar spinal cord. Dev. Brain Res. 112, 39–53 (1999).
  • Jia H, Rustioni A, Valtschanoff JG. Metabotropic glutamate receptors in superficial laminae of the rat dorsal horn. J. Comp. Neural 410, 627–642 (1999).
  • Tao Y, Li Y, Zhao Z, Johns RA. Synaptic relationship of the neurons containing a metabotropic glutamate receptor, mGluR5, with nociceptive primary afferent and GABAergic terminals in rat spinal superficial laminae. Brain Res 875, 138–143 (2000).
  • Fisher K, Coderre TJ. Comparison of nociceptive effects produced by it. administration of mGluR agonists. Neuromport 7, 2743–2747 (1996)
  • Fundytus ME, Fisher K, Dray A, Henry JL, Coderre TJ. In vivo antinociceptive activity of antirat mGluR1 and mGluR5 antibodies in rats. Neuromport 9, 731–735 (1998).
  • Fundytus ME, Yashpal K, Chabot JG et al Knockdown of spinal metabotropic glutamate receptor 1 (mGluR1) alleviates pain and restores opioid efficacy after nerve injury in rats. Br Pharmacol 132, 354–367 (2001).
  • Fisher K, Coderre TJ. Hyperalgesia and allodynia induced by it. (RS)-dihydroxy-phenylglycine administration in rats. Neurarport9, 1169–1172 (1998).
  • Dolan S, Nolan AM. Behavioural evidence supporting a differential role for group I and II metabotropic glutamate receptors in spinal nociceptive transmission. Neuropharmacology39, 1132–1138 (2000).
  • Fisher K, Coderre TJ. The contribution of metabotropic glutamate receptors (mGluRs) to formalin-induced nociception. Pain 68, 255–263 (1996).
  • Young MR, Blackburn-Munro G, Dickinson T et al Antisense ablation of Type I metabotropic glutamate receptor mGluR1 inhibits spinal nociceptive transmission. j Aill11:6Ci. 18, 10180–10188 (1998).
  • Young MR, Fleetwood-Walker SM, Dickinson T et al. Behavioural and electrophysiological evidence supporting a role for group I metabotropic glutamate receptors in the mediation of nociceptive inputs to the rat spinal cord. Brain Res. 777, 161–169 (1997).
  • Stanfa LC, Dickenson AH. Inflammation alters the effects of mGlu receptor agonists on spinal nociceptive neurons. Eur. Pharmacol 347, 165–172 (1998).
  • Neugebauer V, Chen PS, Willis WD. Role of metabotropic glutamate receptor subtype mGluR1 in brief nociception and central sensitization of primate STT cells. J. Neurophysiol 82, 272–282 (1999).
  • ••This electrophysiological study shows that aselective mGluRl antagonist reduces central sensitization in spinothalamic tract neurons.
  • Ugolini A, Corsi M, Bordi E Potentiation of NMDA and AMPA responses by the specific mGluR5 agonist CHPG in spinal cord motoneurons. Neuropharmacology38, 1569–1576 (1999).
  • Fisher K, Fundytus ME, Cahill CM, Coderre TJ. Intrathecal administration of the mGluR compound, (S)-4CPG, attenuates hyperalgesia and allodynia associated with sciatic nerve constriction injury in rats. Pain 77, 59–66 (1998).
  • Zou X, Lin Q, Willis WD. Enhanced phosphorylation of NMDA receptor 1 subunits in spinal cord dorsal horn and spinothalamic tract neurons after intradermal injection of capsaicin in rats. J. Neurosci. 20, 6989–6997 (2000).
  • Bordi F, Ugolini A. Involvement of mGluR5 on acute nociceptive transmission. Brain Res. 871, 223–233 (2000).
  • Azkue JJ, Murga M, Fernandez-Capetillo O et al. Immunoreactivity for the group III metabotropic glutamate receptor subtype mGluR4a in the superficial laminae of the rat spinal dorsal horn. J. Comp. Neural 430, 448–457 (2001).
  • Kinoshita A, Shigemoto R, Ohishi H, van der Putten H, Mizuno N. Immunohistochemical localization of metabotropic glutamate receptors, mGluR7a and mGluR7b, in the central nervous system of the adult rat and mouse: a light and electron microscopic study. Comp. New& 393, 332–352 (1998).
  • Ohishi H, Akazawa C, Shigemoto R, Nakanishi S, Mizuno N. Distributions of the mRNAs for L-2-amino-4-phosphonobutyrate-sensitive metabotropic glutamate receptors, mGluR4 and mGluR7, in the rat brain. J. Comp. Neural. 360, 555–570 (1995).
  • Ohishi H, Shigemoto R, Nakanishi S, Mizuno N. Distribution of the messenger RNA for a metabotropic glutamate receptor, mGluR2, in the central nervous system. Aiumscience 53, 1009–1018 (1993).
  • Ohishi H, Shigemoto R, Nakanishi S, Mizuno N. Distribution of the mRNA for a metabotropic glutamate receptor (mGluR3) in the rat brain: an in situ hybridization study. I Comp. Neural. 335, 252–266 (1993).
  • Cao CQ, Tse HW, Jane DE, Evans RII, Headley PM. Metabotropic glutamate receptor antagonists, like GABA(B) antagonists, potentiate dorsal root-evoked excitatory synaptic transmission at neonatal rat spinal motoneurons in vitro. Neuroscience 78, 243–250 (1997).
  • Cao CQ, Tse HW, Jane DE, Evans RII, Headley PM. Antagonism of mGlu receptors and potentiation of EPSCs at rat spinal motoneurones in vitro. Neuropharmacology36, 313–318 (1997).
  • Dong XW, Feldman JL. Distinct subtypes of metabotropic glutamate receptors mediate differential actions on excitability of spinal respiratory motoneurons. Neumsci. 19, 5173–5184 (1999).
  • Gerber G, Zhong J, Youn D, Randic M. Group II and group III metabotropic glutamate receptor agonists depress synaptic transmission in the rat spinal cord dorsal horn. Neuroscience 100, 393–406 (2000).
  • Jane DE, Thomas NK, Tse HW, Watkins JC. Potent antagonists at the L-AP4- and (1S,35)-ACPD-sensitive presynaptic metabotropic glutamate receptors in the neonatal rat spinal cord. Neumpharmacology 35, 1029–1035 (1996).
  • King AE, Liu XH. Dual action of metabotropic glutamate receptor agonists on neuronal excitability and synaptic transmission in spinal ventral horn neurons in vitro. Neuropharmacology35, 1673–1680 (1996).
  • Dougherty PM, Palecek J, Paleckov6. V, Willis WD. The role of NMDA and non-NMDA excitatory amino acid receptors in the excitation of primate spinothalamic tract neurons by mechanical, chemical, thermal and electrical stimuli. J. Neurosci 12, 3025–3041 (1992).
  • Lin Q, Peng YB, Willis WD. Inhibition of primate spinothalamic tract neurons by spinal glycine and GABA is reduced during central sensitization. J. Neurophysiol 76, 1005–1014 (1996).
  • Boxall SJ, Berthele A, Laurie DJ eta]. Enhanced expression of metabotropic glutamate receptor 3 messenger RNA in the rat spinal cord during ultraviolet irradiation induced peripheral inflammation. Neumscience 82, 591–602 (1998).
  • Willis WD, Zhang X, Honda CN, Giesler GJ. Projections from the marginal zone and deep dorsal horn to the ventrobasal nuclei of the primate thalamus. Pain 92, 267–276 (2001).
  • Salt TE, Eaton SA. Functions of ionotropic and metabotropic glutamate receptors in sensory transmission in the mammalian thalamus. Pay: Neumbial 48, 55–72 (1996).
  • Neto FL, Schadrack J, Berthele A, Zieglgänsberger W Tolle TR, Castro-Lopes JM. Differential distribution of metabotropic glutamate receptor subtype mRNAs in the thalamus of the rat. Brain Res. 854, 93–105 (2000).
  • Salt TE, Binns KE. Contributions of mGlul and mG1u5 receptors to interactions with N-methyl-D-aspartate receptor-mediated responses and nociceptive sensory responses of rat thalamic neurons. Neuroscience. 100, 375–380 (2000).
  • ••This electrophysiological study shows that nociceptive, but not non-nociceptive, responses of thalamic neurons are reduced by selective mGluR1 and mGluR5 antagonists.
  • Salt TE, Binns KE, Turner JP, Gasparini F, Kuhn R. Antagonism of the mG1u5 agonist 2-chloro-5-hydroxyphenylglycine by the novel selective mG1u5 antagonist 6-methyl-2-(phenylethyny1)-pyridine (MPEP) in the thalamus. Br. Pharmacol 127, 1057–1059 (1999).
  • Salt TE, Turner JR Reduction of sensory and metabotropic glutamate receptor responses in the thalamus by the novel metabotropic glutamate receptor-1-selective antagonist S-2-methy1-4-carboxy-phenylglycine. Neuroscience 85, 655–658 (1998).
  • Salt TE, Turner JP, Kingston AE. Evaluation of agonists and antagonists acting at Group I metabotropic glutamate receptors in the thalamus in vivo. Neuropharmacology38, 1505–1510 (1999).
  • Salt TE, Turner JR Modulation of sensory inhibition in the ventrobasal thalamus via activation of group II metabotropic glutamate receptors by 2R,4R-aminopyrrolidine-2,4-dicarboxylate. Exp. Brain Res 121, 181–185 (1998).
  • Binns KE, Salt TE. Actions of the systemically active metabotropic glutamate antagonist MPEP on sensory responses of thalamic neurones. Neurophalmacology 40, 639–644 (2001).
  • Salt TE, Eaton SA, Turner JP. Characterization of the metabotropic glutamate receptors (mGluRs) which modulate GABA-mediated inhibition in the ventrobasal thalamus. Neurochem. 29, 317–322 (1996).
  • Neto FL, Castro-Lopes JM. Antinociceptive effect of a group II metabotropic glutamate receptor antagonist in the thalamus of monoarthritic rats. Neurosci. Lett. 296, 25–28 (2000).
  • Jasmin L, Burkey AR, Card JP, Basbaum Al. Transneuronal labeling of a nociceptive pathway, the spino-(trigemino-)parabrachio-amygdaloid, in the rat. j Neurosci 17, 3751–3765 (1997).
  • Neugebauer V, Li W Processing of nociceptive mechanical and thermal information in neurons of the central nucleus of the amygdala with knee joint input. J. Neurophysiol (In Press).
  • Shi CJ, Davis M. Pain pathways involved in fear conditioning measured with fear potentiated startle: lesion studies. J Neurosci 19, 420–430 (1999).
  • Martin LJ, Blackstone CD, Huganir RL, Price DL. Cellular localization of a metabotropic glutamate receptor in rat brain. Neumne 9, 259–270 (1992).
  • Masugi M, Yokoi M, Shigemoto R et al. Metabotropic glutamate receptor subtype 7 ablation causes deficit in fear response and conditioned taste aversion. j Neurosci 19, 955–963 (1999).
  • Ohishi H, Neki A, Mizuno N. Distribution of a metabotropic glutamate receptor, mGluR2, in the central nervous system of the rat and mouse: an immunohistochemical study with a monoclonal antibody. Ailtrosci. Res 30, 65–82 (1998).
  • Li W, Neugebauer V. Differential effects of antagonists at metabotropic glutamate receptor subtypes mGluR1 and mGluR5 in central amygdala (CeA) neurons in a model of arthritic pain. Soc. Neurosci. Abstc 26, 2183 (2000).
  • Schulz B, Fendt M, Gasparini F, Lingenhohl K, Kuhn R, Koch M. The metabotropic glutamate receptor antagonist 2-methyl-6-(phenylethyny1)-pyridine (MPEP) blocks fear conditioning in rats. Neurophatmacology 411–7 (2001).
  • Tatarczynska E, Klodzinska A, Chojnacka-Wojcik E et al Potential anxiolytic- and antidepressant-like effects of MPEP, a potent, selective and systemically active mG1u5 receptor antagonist. BE j Pharmacol. 132, 1423–1430 (2001).
  • Neugebauer V, Li W Antinociceptive effects of a group II metabotropic glutamate receptor agonist in the amygdala in the arthritis pain model. j Pain 2, 26 (2001).
  • Neugebauer V, Zinebi F, Russell R, Gallagher JP, Shinnick-Gallagher P Cocaine and kindling alter the sensitivity of group II and III metabotropic glutamate receptors in the central amygdala. Neurophysiol. 84, 759–770 (2000).
  • Klodzinska A, Chojnacka-Wojcik E, Palucha A, Branski P, Popik P, Pilc A. Potential anti-anxiety, anti-addictive effects of LY 354740, a selective group II glutamate metabotropic receptors agonist in animal models. Neuropharmacology38, 1831–1839 (1999).
  • Monn JA, Valli MJ, Massey SM et al. Design, synthesis and pharmacological characterization of (+)-2-aminobicydo[3.1.01hexane-2,6-dicarboxylic acid (LY3547401: a potent, selective and orally-active group 2 metabotropic glutamate receptor agonist possessing anticonvulsant and anxiolytic properties. I Med. Chem. 40, 528–537 (1997).
  • Lebedeva I, Stein CA. Antisense oligonudeotides: promise and reality. Ann. Rev Phatmacol. TOxicol 41, 403–419 (2001).
  • Wahlestedt C, Salmi P, Good L eta] Potent and nontoxic antisense oligonucleotides containing locked nucleic acids. Proc. Natl Acad. Sci. USA 97, 5633–5638 (2000).
  • Bruno V, Battaglia G, Ksiazek I eta] Selective activation of mG1u4 metabotropic glutamate receptors is protective against excitotoxic neuronal death. J. Neurosci 20, 6413–6420 (2000).
  • Conquet F, Bashir ZI, Davies CH eta]. Motor deficit impairment of synaptic plasticity in mice lacking mGluRl. Nature 372, 237–243 (1994).
  • Lu YM, Jia Z, Janus C eta]. Mice lacking metabotropic glutamate receptor 5 show impaired learning and reduced CA1 long-term potentiation (LTP), but normal CA3 LTP I Neurosci 17, 5196–5205 (1997).
  • Pekhletski R, Gerlai R, Oveistreet LS et al. Impaired cerebellar synaptic plasticity and motor performance in mice lacking the mGluR4 subtype of metabotropic glutamate receptor. J. Neumsci 16, 6364–6373 (1996).
  • Tagawa Y, Sawai H, Ueda Y, Tauchi M, Nakanishi S. Immunohistological studies of metabotropic glutamate receptor subtype 6-deficient mice show no abnormality of retinal cell organization and ganglion cell maturation. J. Neurosci 19, 2568–2579 (1999).
  • Yokoi M, Kobayashi K, Manabe T eta]. Impairment of hippocampal mossy fiber LTD in mice lacking mGluR2. Science 273, 645–647 (1996).
  • Toms NJ, Roberts PJ, Salt TE, Staton PC. Latest eruptions in metabotropic glutamate receptors. Trends Pharmacol St". 17, 429–435 (1996).
  • Lariviere WR, Chesler EJ, Mogil JS. Transgenic Studies of Pain and Analgesia: Mutation or Background Genotype? J. Phatmacol. Exp. Ther. 297, 467–473 (2001).
  • Mogil JS, Yu L, Basbaum Pd. Pain genes? Natural variation and transgenic mutants. Ann. Rev Neurosci 23, 777–811 (2000).
  • Kuhn R, Schwenk E Advances in gene targeting methods. CI.117: Opin. Immunol 9, 183–188 (1997).
  • Mayford M, Kandel ER. Genetic approaches to memory storage. TIC 15, 463–470 (2001).
  • •Genetic strategies reviewed in this article may also be applicable to pain research.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.